ASML Q1 Earnings Beat and Guidance Raise Meet DeepValue's Critical Checkpoint Amid High Valuation

What happened

ASML reported Q1 2026 earnings that surpassed analyst expectations, raising its full-year revenue guidance while reaffirming its gross margin outlook. This action directly aligns with a key signal highlighted in the DeepValue master report, which stressed that reaffirming the €36B–€40B revenue and 51%–53% gross margin framework is essential for maintaining the investment thesis. The guidance increase reflects ASML's confidence in converting its €38.8B backlog, driven by strong AI-related demand for EUV lithography systems, as noted in the report. However, the stock trades at $1,442 with a high P/E of 49.2 and EV/EBITDA of 37, embedding flawless execution and leaving little margin for error. While this news supports the bullish narrative, it does not mitigate the ongoing risks of export-control expansion into installed-base services or potential shipment cadence shortfalls that could undermine the thesis.

Implication

Investors should interpret the guidance increase as a positive step that reduces uncertainty around ASML's ability to meet 2026 targets, supporting its role as an AI capex beneficiary. This aligns with the DeepValue report's emphasis on monitoring quarterly reaffirmations to gauge demand and policy resilience. However, the stock's premium valuation at 49.2x P/E means any deviation from expected EUV shipment cadence or export-control tightening could lead to significant multiple compression. The report identifies specific risks, such as potential restrictions on maintenance services in China, which could impair high-margin installed-base revenue and are not addressed by this news. Therefore, while the outlook is strengthened, investors should await further evidence on shipment execution and policy developments before adjusting positions, maintaining a cautious stance as per the WAIT recommendation.

Thesis delta

The news confirms a key positive signal from the DeepValue report—the reaffirmation of 2026 guidance—which was a condition for potentially upgrading the thesis. However, it does not alter the core investment call, as the high valuation and other critical risks, such as export-control expansion and shipment cadence tracking, remain unaddressed. Thus, the WAIT rating persists, with the probability of the base case slightly increased but still requiring further validation over the next 3-6 months.